You are seeing these quotes based on previous browsing related to sectors such as
Latest | Forecast | |
---|---|---|
Div Yield | 0.0% | n/a |
Div Cover | n/a | n/a |
Op Mrgn | -358.6% | n/a |
ROCE | 0.0% |
Latest | Forecast | |
---|---|---|
P/E | -0.4 | n/a |
PEG | 0.0 | n/a |
Price / Revenue | 6.6 | n/a |
Price / Book value | 6.4 |
Latest | Forecast | |
---|---|---|
Revenue | -50.9% | n/a |
PBT | 0.0% | n/a |
EPS | 0.0% | n/a |
DPS | n/a | n/a |
Year Ending | Revenue (£m) |
Pre-tax (£m) |
EPS | P/E | PEG | EPS Growth | Div | Yield |
---|---|---|---|---|---|---|---|---|
2021-06-30 | 1.60 | -2.91 | -3.92p | 0.0 | 0.0 | n/a | n/a | 0.0% |
2022-06-30 | 4.04 | -2.64 | -3.24p | -29.6 | 0.0 | n/a | n/a | 0.0% |
2023-06-30 | 1.75 | -8.30 | -11.35p | -0.6 | 0.0 | n/a | n/a | 0.0% |
2024-06-30 | 0.86 | -3.14 | -0.71p | -0.9 | 0.0 | n/a | n/a | 0.0% |
Aptamer extends contract with Unilever Sharecast News | 03 Sep |
---|---|
Aptamer reports success in ongoing work with Unilever Sharecast News | 08 Jul |
Aptamer enters partnership with Microsaic Systems Sharecast News | 14 Jun |
Agreement extended with genetic medicines customer | 07-Nov-24 07:02 |
---|---|
Commercial Trading Update | 06-Nov-24 07:01 |
Posting of Annual Report and Notice of AGM | 05-Nov-24 07:01 |
Full Year Results for the 12mths to 30 June 2024 | 22-Oct-24 07:01 |
Notice of Results and Investor Presentation | 17-Oct-24 07:03 |